Alvin DeGuzman of Icarus Line Diagnosed With Cancer and Has Started a GoFundMe Page For Treatment

Los Angeles post-hardcore act Icarus Line’s founding member Alvin DeGuzman was diagnosed with a rare form of bone cancer some two years ago, was treated and went into remission. Tragically, the cancer has now returned, spread and has reached a very advanced stage.

His parents have set up a GoFundMe page to raise funds to manufacture an innovative treatment, not yet on the market that has cured patients of advanced stage cancers. This is his parents’ statement:

“Two years ago at age 36, our son Alvin, a professional musician, developed a rare type of bone cancer, mesenchymal chondrosarcoma, that caused sudden paralysis of his legs up to his chest. Today, his cancer has returned with a vengeance, and the cancer has spread to his liver, lungs and bones! We have to act fast as his treatment options are few and his time is running out!

In our quest to save his life, we read about a new version of a genetic medicine that has cured patients with bone cancer and pancreatic cancer. We are optimistic that if Alvin can be treated with this medicine, he has a chance of winning his battle against cancer.

The challenge we face is the high cost of drug manufacturing. Through gofundme.com, we are raising the $350,000 needed to make the drug. If this treatment works for Alvin, it will open the door to other cancer patients who could benefit from this treatment as well! We pray that you will help us raise the funds needed. This is an urgent matter; the sooner we get the funding, the sooner we can start Alvin’s cure! Please help us SAVE ALVIN FROM CANCER and in so doing, SAVE OTHER CANCER VICTIMS!”

Here is the link to DeGuzman’s GoFundMe page.

Christopher Lee: I am a college student from California. I am a massive fan of most things rock, and especially of all things Car Seat Headrest. Journalism has been a great passion of mine, and I hope that I'll be able to continue to merge my worlds of music and journalism as the years go on.
Related Post
Leave a Comment